Company Profile

Esco Lifesciences Group (hereinafter referred to as "Esco Lifesciences") is a manufacturer of laboratory equipment, pharmaceutical equipment, biotechnology, and assisted reproductive medical equipment, providing sustainable workflow solutions to promote the development of global health.

Yishike Biotechnology was founded in Singapore in 1978, with a commitment to cutting-edge technology, rapid response services, and reliable quality. Its products and services cover more than 150 countries worldwide, with 8 production and research and development centers and over 1700 employees worldwide.

In 2025, Yishike Biotechnology's headquarters in China will undergo a comprehensive upgrade to its new location in Shanghai, and will continue to increase its investment in China and deeply cultivate the Chinese market.

Corporate Culture

Our vision:
Esco's strategic positioning is to serve as a bridge connecting the East and the West, committed to becoming an outstanding supplier in the fields of life sciences and reproductive tools, providing sustainable technologies, and promoting a healthier, fairer, and more resilient future.

Our mission:

We provide cutting-edge and sustainable workflow solutions for scientists and innovators, promoting global health and improving quality of life.

Value proposition:

We specialize in tailoring innovative, high-value equipment and technologies for the life sciences and healthcare markets. We pursuehigher qualityEnsure the provision of top-quality products and excellent services.

Esco Core Values:

·Attitude

·communication

·ability

·commitment

·growth

·Integrity

Esco Product Overview:

Biosafety and Cleanliness Products: A2 Type Biosafety Cabinet, B2 Type Biosafety Cabinet, Level 3 Biosafety Cabinet, Laboratory Animal Research Safety Cabinet, Horizontal Laminar Flow Ultra Clean Workbench, Vertical Laminar Flow Ultra Clean Workbench, PCR Special Ultra Clean Workbench

Ventilation hood: laboratory ventilation hood, ductless ventilation hood

Incubator and oven: carbon dioxide incubator, full temperature oscillation incubator, remote monitoring data recording and programmable software

Gene Amplification Device: Gradient Gene Amplification Device

Low temperature storage products: vertical ultra-low temperature refrigerator, laboratory refrigerator, laboratory freezer, liquid nitrogen biological container, IVF specific multi chamber incubator, IVF specific validation equipment, anti vibration micro operation test bench

Assisted reproductive technology products: ART workstation, oxygen suppressing carbon dioxide culture

Clean pharmaceutical products: sterile testing isolators, clean laminar flow weighing rooms, powder sample weighing cabinets, isolated drug operation safety cabinets

Centrifuge: laboratory bench micro centrifuge, laboratory bench universal centrifuge

Pipette: Single channel electric pipette, multi channel electric pipette

Overview of Esco China's Development

In 2002, Esco's life science instrument products fully entered the Chinese market

In 2005, Esco China Beijing Representative Office was established

In 2006, Esco China Shanghai Representative Office was established

In 2006, Esco obtained the expert assessment qualification for biosafety cabinet certification authorized by NSF in the United States

In 2006, Esco's biosafety cabinet passed the Chinese YY0569-2005 certification and obtained the Import Product Class III Medical Device Registration Certificate issued by the Chinese SFDA

In 2007, Esco China Guangzhou Representative Office was established

In 2007, Esco Corporation launched a product developed in collaboration with Lawrence Berkeley National Laboratory in the United States

In 2008, Esco China's "Yisigao (Shanghai) Trading Co., Ltd." was registered and established

In 2008, Esco became a formal member of the NSF certification body in the United States with the qualification to review

In 2010, Esco globally launched CO2 incubators simultaneously

In 2012, Esco China Chengdu Representative Office was established

In 2012, Esco's new carbon dioxide incubator CelMate series and all copper inner liner products were launched

In 2016, Esco's Qingdao office in China was officially established

In 2018, Esco established an incubation platform in Beijing

In July 2018, Esco Group officially started construction on its 20000m2 Suzhou R&D and production base in China

In 2020, Yishike Pharmaceutical Division officially entered the CDMO field

In 2021, Yishike Biotechnology entered the 3.0 era and transformed into a life science tool and service platform

In 2022, Yishike Pharmaceutical Machinery Division officially landed in China